# Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19

> **NCT04748783** · PHASE2 · TERMINATED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 2 (actual)

## Conditions studied

- COVID19
- Coronavirus Infection
- SARS CoV-2 Infection

## Interventions

- **OTHER:** Water
- **OTHER:** Peroxyl
- **DRUG:** Periogard
- **OTHER:** Colgate Total Zero

## Key facts

- **NCT ID:** NCT04748783
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-03-26
- **Primary completion:** 2021-04-07
- **Final completion:** 2021-04-07
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Funding withdrawn
- **Last updated:** 2022-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04748783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04748783, "Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04748783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*